カテゴリー： 世界, 医療/バイオ, P&S Market Research

移植診断のグローバル市場：技術別、提供品目別、移植タイプ別、用途別、エンドユーザー別

P&S Market Researchが出版した調査資料（PS24MAR058）・商品コード：PS24MAR058
・発行会社（調査会社）：P&S Market Research
・発行日：2023年12月
・ページ数：340
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Group UserUSD6,400 ⇒換算￥972,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,400 ⇒換算￥1,276,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

2023年の移植診断市場は4,686.7百万米ドルで、この10年の終わりまでに7.5％の成長率で成長し、2030年には7,713.5百万米ドルに達します。
これは、臓器置換術の必要性が高まっていること、臓器置換術前の診断処置の必要性が高まっていること、感染症が増加していることに起因しています。
また、最終段階の臓器不全の患者数は増加傾向にあり、臓器移植手術の発展により、多くの患者がこれらの手術を受けられるようになりました。
技術別では、分子アッセイが2023年に65％のシェアで業界をリードしており、今後も優位を保つでしょう。
これは、分子アッセイがレシピエントとドナーの適合性を検査するための手術前診断プロセスで広く使用されているという事実によるものです。これらのアッセイは、非分子アッセイとは対照的に、多数のサンプルの研究、瞬時の分析、高い手続き上の有効性など、技術的な利点があるため、主に受け入れられています。

ソフトウェア＆サービス部門は今後最も急速に成長するでしょう。これは、市場プレーヤーが提供するソフトウェアの定期的なアップデートと充実したサービスが競争に残っているためです。
さらに、より先進的な機器の拡大により、技術職員に機器の取り扱いや使い方を教えるための講習会の需要が急増しています。これらの要因が業界の進化をもたらしました。

2023年の移植診断市場は、診断薬カテゴリーが70％のシェアを占めており、今後もこの傾向が続くと思われます。これは病気の発生が増加しているためです。
さらに、診断カテゴリーは移植前診断と移植後診断に分けられます。さらに、移植プロセスでは、移植の適合性を見るために、移植前にすべての相対的な診断テストが行われます。例えば、血液プロファイリング、組織適合性テスト、伝染病テストなどです。
2023年には北米が50％と最大のシェアを占め、今後もこの傾向は続くでしょう。これには、最先端の技術や分析ツールの高い受容率、高い医療費、熟練した専門家の入手可能性、軟部組織移植、幹細胞療法、オーダーメイド薬の広範な使用が大きく関係しています。

さらに、臓器移植の件数の増加、移植に対する意識の高まり、伝染病の罹患率の増加、慢性疾患にかかりやすい高齢者人口の増加が、この業界の原動力となっています。
世界中で臓器移植の件数が増加しており、これが移植診断ソリューションの需要を後押ししています。この傾向は今後数年間も続くでしょう。

移植診断のトップ・プロバイダーは以下の通りです：
bioMérieux S.A.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Hologic Inc.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings
BAG Diagnostics GmbH
Illumina Inc.

第1章．調査範囲
第2章．調査方法
第3章．エグゼクティブサマリー
第4章．市場指標
第5章．産業動向
第6章．世界市場
第7章．北米市場
第8章．ヨーロッパ市場
第9章．アジア太平洋市場
第10章．中南米市場
第11章．中東/アフリカ市場
第12章．アメリカ市場
第13章．カナダ市場
第14章．ドイツ市場
第15章．フランス市場
第16章．イギリス市場
第17章．イタリア市場
第18章．スペイン市場
第19章．日本市場
第20章．中国市場
第21章．インド市場
第22章．オーストラリア市場
第23章．韓国市場
第24章．ブラジル市場
第25章．メキシコ市場
第26章．サウジアラビア市場
第27章．南アフリカ市場
第28章．中東市場
第29章．競争状況
第30章．企業情報
第31章．付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by technology

1.4.2. Market size breakdown, by offering

1.4.3. Market size breakdown, by transplant type

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by application

1.4.6. Market size breakdown, by region

1.4.7. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Revenue, by Technology (2017–2030)

6.2.1. Molecular assay market revenue, by type (2017–2030)

6.2.2. Non-molecular assay market revenue, by type (2017–2030)

6.3. Market Revenue, by Offering (2017–2030)

6.4. Market Revenue, by Transplant Type (2017–2030)

6.4.1. Solid organ market revenue, by type (2017–2030)

6.5. Market Revenue, by Application (2017–2030)

6.6. Market Revenue, by End User (2017–2030)

6.7. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Revenue, by Technology (2017–2030)

7.2.1. Molecular assay market revenue, by type (2017–2030)

7.2.2. Non-molecular assay market revenue, by type (2017–2030)

7.3. Market Revenue, by Offering (2017–2030)

7.4. Market Revenue, by Transplant Type (2017–2030)

7.4.1. Solid organ market revenue, by type (2017–2030)

7.5. Market Revenue, by Application (2017–2030)

7.6. Market Revenue, by End User (2017–2030)

7.7. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Revenue, by Technology (2017–2030)

8.2.1. Molecular assay market revenue, by type (2017–2030)

8.2.2. Non-molecular assay market revenue, by type (2017–2030)

8.3. Market Revenue, by Offering (2017–2030)

8.4. Market Revenue, by Transplant Type (2017–2030)

8.4.1. Solid organ market revenue, by type (2017–2030)

8.5. Market Revenue, by Application (2017–2030)

8.6. Market Revenue, by End User (2017–2030)

8.7. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Revenue, by Technology (2017–2030)

9.2.1. Molecular assay market revenue, by type (2017–2030)

9.2.2. Non-molecular assay market revenue, by type (2017–2030)

9.3. Market Revenue, by Offering (2017–2030)

9.4. Market Revenue, by Transplant Type (2017–2030)

9.4.1. Solid organ market revenue, by type (2017–2030)

9.5. Market Revenue, by Application (2017–2030)

9.6. Market Revenue, by End User (2017–2030)

9.7. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Revenue, by Technology (2017–2030)

10.2.1. Molecular assay market revenue, by type (2017–2030)

10.2.2. Non-molecular assay market revenue, by type (2017–2030)

10.3. Market Revenue, by Offering (2017–2030)

10.4. Market Revenue, by Transplant Type (2017–2030)

10.4.1. Solid organ market revenue, by type (2017–2030)

10.5. Market Revenue, by Application (2017–2030)

10.6. Market Revenue, by End User (2017–2030)

10.7. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Revenue, by Technology (2017–2030)

11.2.1. Molecular assay market revenue, by type (2017–2030)

11.2.2. Non-molecular assay market revenue, by type (2017–2030)

11.3. Market Revenue, by Offering (2017–2030)

11.4. Market Revenue, by Transplant Type (2017–2030)

11.4.1. Solid organ market revenue, by type (2017–2030)

11.5. Market Revenue, by Application (2017–2030)

11.6. Market Revenue, by End User (2017–2030)

11.7. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Revenue, by Technology (2017–2030)

12.2.1. Molecular assay market revenue, by type (2017–2030)

12.2.2. Non-molecular assay market revenue, by type (2017–2030)

12.3. Market Revenue, by Offering (2017–2030)

12.4. Market Revenue, by Transplant Type (2017–2030)

12.4.1. Solid organ market revenue, by type (2017–2030)

12.5. Market Revenue, by Application (2017–2030)

12.6. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Revenue, by Technology (2017–2030)

13.2.1. Molecular assay market revenue, by type (2017–2030)

13.2.2. Non-molecular assay market revenue, by type (2017–2030)

13.3. Market Revenue, by Offering (2017–2030)

13.4. Market Revenue, by Transplant Type (2017–2030)

13.4.1. Solid organ market revenue, by type (2017–2030)

13.5. Market Revenue, by Application (2017–2030)

13.6. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Revenue, by Technology (2017–2030)

14.2.1. Molecular assay market revenue, by type (2017–2030)

14.2.2. Non-molecular assay market revenue, by type (2017–2030)

14.3. Market Revenue, by Offering (2017–2030)

14.4. Market Revenue, by Transplant Type (2017–2030)

14.4.1. Solid organ market revenue, by type (2017–2030)

14.5. Market Revenue, by Application (2017–2030)

14.6. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Revenue, by Technology (2017–2030)

15.2.1. Molecular assay market revenue, by type (2017–2030)

15.2.2. Non-molecular assay market revenue, by type (2017–2030)

15.3. Market Revenue, by Offering (2017–2030)

15.4. Market Revenue, by Transplant Type (2017–2030)

15.4.1. Solid organ market revenue, by type (2017–2030)

15.5. Market Revenue, by Application (2017–2030)

15.6. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Revenue, by Technology (2017–2030)

16.2.1. Molecular assay market revenue, by type (2017–2030)

16.2.2. Non-molecular assay market revenue, by type (2017–2030)

16.3. Market Revenue, by Offering (2017–2030)

16.4. Market Revenue, by Transplant Type (2017–2030)

16.4.1. Solid organ market revenue, by type (2017–2030)

16.5. Market Revenue, by Application (2017–2030)

16.6. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Revenue, by Technology (2017–2030)

17.2.1. Molecular assay market revenue, by type (2017–2030)

17.2.2. Non-molecular assay market revenue, by type (2017–2030)

17.3. Market Revenue, by Offering (2017–2030)

17.4. Market Revenue, by Transplant Type (2017–2030)

17.4.1. Solid organ market revenue, by type (2017–2030)

17.5. Market Revenue, by Application (2017–2030)

17.6. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Revenue, by Technology (2017–2030)

18.2.1. Molecular assay market revenue, by type (2017–2030)

18.2.2. Non-molecular assay market revenue, by type (2017–2030)

18.3. Market Revenue, by Offering (2017–2030)

18.4. Market Revenue, by Transplant Type (2017–2030)

18.4.1. Solid organ market revenue, by type (2017–2030)

18.5. Market Revenue, by Application (2017–2030)

18.6. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Revenue, by Technology (2017–2030)

19.2.1. Molecular assay market revenue, by type (2017–2030)

19.2.2. Non-molecular assay market revenue, by type (2017–2030)

19.3. Market Revenue, by Offering (2017–2030)

19.4. Market Revenue, by Transplant Type (2017–2030)

19.4.1. Solid organ market revenue, by type (2017–2030)

19.5. Market Revenue, by Application (2017–2030)

19.6. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Revenue, by Technology (2017–2030)

20.2.1. Molecular assay market revenue, by type (2017–2030)

20.2.2. Non-molecular assay market revenue, by type (2017–2030)

20.3. Market Revenue, by Offering (2017–2030)

20.4. Market Revenue, by Transplant Type (2017–2030)

20.4.1. Solid organ market revenue, by type (2017–2030)

20.5. Market Revenue, by Application (2017–2030)

20.6. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Revenue, by Technology (2017–2030)

21.2.1. Molecular assay market revenue, by type (2017–2030)

21.2.2. Non-molecular assay market revenue, by type (2017–2030)

21.3. Market Revenue, by Offering (2017–2030)

21.4. Market Revenue, by Transplant Type (2017–2030)

21.4.1. Solid organ market revenue, by type (2017–2030)

21.5. Market Revenue, by Application (2017–2030)

21.6. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Revenue, by Technology (2017–2030)

22.2.1. Molecular assay market revenue, by type (2017–2030)

22.2.2. Non-molecular assay market revenue, by type (2017–2030)

22.3. Market Revenue, by Offering (2017–2030)

22.4. Market Revenue, by Transplant Type (2017–2030)

22.4.1. Solid organ market revenue, by type (2017–2030)

22.5. Market Revenue, by Application (2017–2030)

22.6. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Revenue, by Technology (2017–2030)

23.2.1. Molecular assay market revenue, by type (2017–2030)

23.2.2. Non-molecular assay market revenue, by type (2017–2030)

23.3. Market Revenue, by Offering (2017–2030)

23.4. Market Revenue, by Transplant Type (2017–2030)

23.4.1. Solid organ market revenue, by type (2017–2030)

23.5. Market Revenue, by Application (2017–2030)

23.6. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Revenue, by Technology (2017–2030)

24.2.1. Molecular assay market revenue, by type (2017–2030)

24.2.2. Non-molecular assay market revenue, by type (2017–2030)

24.3. Market Revenue, by Offering (2017–2030)

24.4. Market Revenue, by Transplant Type (2017–2030)

24.4.1. Solid organ market revenue, by type (2017–2030)

24.5. Market Revenue, by Application (2017–2030)

24.6. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Revenue, by Technology (2017–2030)

25.2.1. Molecular assay market revenue, by type (2017–2030)

25.2.2. Non-molecular assay market revenue, by type (2017–2030)

25.3. Market Revenue, by Offering (2017–2030)

25.4. Market Revenue, by Transplant Type (2017–2030)

25.4.1. Solid organ market revenue, by type (2017–2030)

25.5. Market Revenue, by Application (2017–2030)

25.6. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Revenue, by Technology (2017–2030)

26.2.1. Molecular assay market revenue, by type (2017–2030)

26.2.2. Non-molecular assay market revenue, by type (2017–2030)

26.3. Market Revenue, by Offering (2017–2030)

26.4. Market Revenue, by Transplant Type (2017–2030)

26.4.1. Solid organ market revenue, by type (2017–2030)

26.5. Market Revenue, by Application (2017–2030)

26.6. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Revenue, by Technology (2017–2030)

27.2.1. Molecular assay market revenue, by type (2017–2030)

27.2.2. Non-molecular assay market revenue, by type (2017–2030)

27.3. Market Revenue, by Offering (2017–2030)

27.4. Market Revenue, by Transplant Type (2017–2030)

27.4.1. Solid organ market revenue, by type (2017–2030)

27.5. Market Revenue, by Application (2017–2030)

27.6. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Revenue, by Technology (2017–2030)

28.2.1. Molecular assay market revenue, by type (2017–2030)

28.2.2. Non-molecular assay market revenue, by type (2017–2030)

28.3. Market Revenue, by Offering (2017–2030)

28.4. Market Revenue, by Transplant Type (2017–2030)

28.4.1. Solid organ market revenue, by type (2017–2030)

28.5. Market Revenue, by Application (2017–2030)

28.6. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. bioMérieux S.A.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Thermo Fisher Scientific Inc.

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Bio-Rad Laboratories Inc.

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. Abbott Laboratories

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. Hologic Inc.

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. F. Hoffmann-La Roche Ltd.

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Laboratory Corporation of America Holdings

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. BAG Diagnostics GmbH

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Illumina Inc.

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports



★調査レポート[移植診断のグローバル市場：技術別、提供品目別、移植タイプ別、用途別、エンドユーザー別] (コード：PS24MAR058)販売に関する免責事項を必ずご確認ください。
★調査レポート[移植診断のグローバル市場：技術別、提供品目別、移植タイプ別、用途別、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の骨髄移植市場（～2030年）：移植タイプ別（自家骨髄移植、同種骨髄移植、その他）、適応疾患別（白血病、リンパ腫、骨髄腫、サラセミア、骨髄異形成症候群、骨髄増殖性疾患、再生不良性貧血、固形腫瘍、鎌状赤血球貧血、その他）、エンドユーザー別、地域別
  • 世界の人工角膜インプラント市場2023-2030：移植タイプ別（硬質人工角膜、軟質人工角膜）、疾患別（眼球熱傷、円錐角膜）、インプラントタイプ別、地域別
  • アレルギー診断のグローバル市場：製品別、アレルゲン別、検査タイプ別、エンドユーザー別
  • センサーフュージョンのグローバル市場：アルゴリズム別、技術別、提供別、エンドユーザー別
  • 世界の移植診断市場（～2028年）：技術別（PCR、NGS、サンガーシーケンシング）、製品別（機器、試薬、ソフトウェア）、用途別（HLA、血液プロファイル、病原体検出）、種類別（心臓、腎臓、肝臓、骨髄）、エンドユーザー別、地域別
  • 世界の臓器＆組織移植市場2023-2030：技術別（同種移植、自家移植、異種移植、その他）、用途別（腎不全、肝硬変、糖尿病、心不全、肺疾患、その他）、種類別（腎臓、肝臓、心臓、肺、膵臓、角膜、その他）、供給源別（死亡ドナー、生体ドナー、その他）、エンドユーザー別（病院、移植センター、その他）、地域別
  • 世界のゲノム編集市場（～2030年）：エンドユーザー別（バイオテクノロジー＆製薬会社、学術＆研究機関、受託研究機関）、用途別（遺伝子工学、診断学、創薬＆開発）、技術別（CRISPR、TALEN、ZFN、アンチセンス）、オファリング別（試薬＆消耗品、ソフトウェア＆システム、サービス）
  • 世界の静水圧プレス市場（～2030年）：オファリング別（サービス、システム）、種類別（熱間静水圧プレス、冷間静水圧プレス）、生産能力別（小型、中型、大型）、エンドユーザー別（自動車、航空宇宙＆防衛、エネルギー＆電力、医療、製造）
  • 世界の生物製剤安全性試験市場（～2030年）：オファリング別（機器、消耗品、サービス）、用途別（ワクチン、細胞＆遺伝子治療、血液＆血液ベース製品、モノクローナル抗体）、検査種類別（無菌性、エンドトキシン、バイオバーデン、マイコプラズマ、ウイルス安全性、残留宿主細胞タンパク質＆DNA検出）、エンドユーザー別（CDMO、バイオ医薬品会社、CRO）
  • 世界のHLAタイピング市場（～2028年）：技術別（PCR（SSO、SSP、リアルタイム）、シーケンス（NGS、サンガー））、製品別（装置、試薬、ソフトウェア）、用途別（キメリズム、抗体スクリーニング）、エンドユーザー別（病院、診断ラボ、学術）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆